Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
This guide reviews which stablecoins are compliant and the standards they must meet. It helps you spot red flags and choose compliant options with confidence.
19,334 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Nvidia’s shares hover around the low $200s as AI momentum sustains growth. Bulls argue the stock’s growth trajectory ...
The WHO has declared the latest ebola outbreak a public health emergency of international concern, prompting a wave o...
Tim Cook's travels to China are more than diplomacy. This piece outlines how what cook's trip china could mean for Ap...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
Nvidia stock investors just received a wave of bullish commentary from analysts as AI demand powers data centers and ...
Artificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
NVIDIA confirms a booming Physical AI segment, surpassing $6 billion in annual revenue as robots move from labs to wa...
Greg Abel just sold Berkshire Hathaway's Visa and Mastercard holdings and started a new stake in a stock Warren Buffe...
As Target prepares for its Q1 2026 earnings call, savvy investors want clarity on sales growth, margins, and the path...
The U.S. housing agency released a deregulation roadmap aimed at trimming permit fees, simplifying building codes, an...